Endo (ENDP) Tops Q3 EPS by 3c, Affirms FY Guidance

Endo Int'l (NASDAQ: ENDP) reported Q3 EPS of $1.02, $0.03 better than the analyst estimate of $0.99. Revenue for the quarter came in at $746 million versus the consensus estimate of $736.16 million.

Endo sees FY2015 EPS of $4.50-$4.60, versus the consensus of $4.56. Endo Int'l sees FY2015 revenue of $3.22-3.27 billion, versus the consensus of $3.27 billion.

For earnings history and earnings-related data on Endo Int'l (ENDP) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Ideal Power (IPWR) Tops Q2 EPS by 2c
• Omega Flex (OFLX) Tops Q2 EPS by 27c